GlassScriptPhysician profile
Chris Villar
NPI 1366700361
$5,689.84
in general payments reported to CMS, 2019-2025
13 companies · $1,994 in 2025
The $1,994 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $842 · 2020: $171 · 2021: $519 · 2022: $1,734 · 2023: $398 · 2024: $31.43 · 2025: $1,994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,602 · Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,601.50 |
| Food and Beverage | $821.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,869.15 | 2025 | Quartex, Creo, Excelsius Gps |
| Stryker Corporation | $1,599.68 | 2019-2022 | |
| Depuy Synthes Sales INC. | $777.78 | 2019-2025 | Vivigen Mis Delivery System |
| Medical Device Business Services, INC. | $397.87 | 2023 | Conduit, Expedium, Sentio |
| Boston Scientific Corporation | $350.21 | 2019-2022 | |
| Medtronic USA, INC. | $163.08 | 2019-2020 | |
| Djo, LLC | $152.93 | 2019 | |
| Orthofix Medical, INC. | $124.47 | 2019 | |
| Si-Bone, INC. | $96.19 | 2019 | |
| Providence Medical Technology, INC. | $62.29 | 2025 | |
| Baxter Healthcare | $40.22 | 2019 | |
| Abbott Laboratories | $39.89 | 2024-2025 | Eterna |
| Integra Lifesciences Corporation | $16.08 | 2024 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Certas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Villar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.